Research Catalog

Competitive strategies in the pharmaceutical industry

Title
  1. Competitive strategies in the pharmaceutical industry / edited by Robert B. Helms.
Published by
  1. Washington, D.C. : AEI Press, 1996.

Items in the library and off-site

Filter by

Displaying 1 item

StatusFormatAccessCall numberItem location
Status
Request for on-site useRequest scan
How do I pick up this item and when will it be ready?
FormatTextAccessRequest in advanceCall numberHD9665.5 .C66 1996Item locationOff-site

Details

Additional authors
  1. Helms, Robert B.
  2. American Enterprise Institute for Public Policy Research.
Description
  1. xviii, 376 pages : illustrations; 24 cm
Summary
  1. The growth of government programs and managed care has altered how pharmaceuticals are marketed and sold in the United States. Such change has shortened the expected revenue stream from most products - even though new technologies have increased both the cost and the medical attractiveness of those products.
  2. Managers of government and private health care programs are looking for new ways to reduce the cost of drug benefits, while company R&D managers are seeking ways to speed the regulatory process and develop new markets to cover the increasing cost of research. This volume examines various aspects of the continuing policy dispute and offers several views on the future of the pharmaceutical industry.
Subject
  1. Competition, International
  2. Drugs > Prices
  3. Pharmaceutical industry
Contents
  1. 1. Introduction / Robert B. Helms -- 2. Generics and the Producer Price Index for Pharmaceuticals / Zvi Griliches and Iain M. Cockburn -- 3. An Updated and Extended Study of the Price Growth of Prescription Pharmaceutical Preparations / Ernst R. Berndt and Paul E. Greenberg -- 4. Measuring Quality Change in the Market for Anti-Ulcer Drugs / Valerie Y. Suslow -- Commentary / James H. Sinclair, Joseph M. Jadlow and David I. Kass -- 5. The Uses and Abuses of International Price Comparisons / Patricia M. Danzon -- 6. Industrial Policy and International Competitiveness in the Pharmaceutical Industry / Lacy Glenn Thomas III -- 7. R&D Productivity and Global Market Share in the Pharmaceutical Industry / Donald L. Alexander -- Commentary / Robert Rogowsky, Jonathan Ratner and W. Brian Healy -- 8. The Determinants of Research Productivity in Ethical Drug Discovery / Rebecca Henderson and Iain M. Cockburn --
  2. 9. Prospects for Returns to Pharmaceutical R&D under Health Care Reform / Henry G. Grabowski and John M. Vernon -- 10. Measuring Pharmaceutical Industry Risk and the Cost of Capital / Stewart C. Myers and Lakshmi Shyam-Sunder -- 11. The Effects of Research and Promotion on Rates of Return / Kenneth W. Clarkson -- Commentary / Frederic M. Scherer and William S. Comanor -- 12. New Uses for Old Drugs / J. Howard Beales III -- 13. The Leverage Principle in FDA's Regulation of Information / John E. Calfee -- 14. Costs and Benefits of Cost-Benefit Analysis in Pharmaceutical Promotion and Utilization Decisions / Ronald W. Hansen -- Commentary / William C. MacLeod, Pauline M. Ippolito and Jeffrey S. McCombs -- Commentary / Robert B. Helms, Frederic M. Scherer, Peter Barton Hutt and Claude E. Barfield.
Owning institution
  1. Columbia University Libraries
Bibliography (note)
  1. Includes bibliographical references and index.